Trevena to Release Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021 Mar 05, 2021 7:00am EST
Trevena, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference Feb 22, 2021 7:00am EST
Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy Jan 28, 2021 7:00am EST
Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts Jan 06, 2021 7:00am EST
Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting Dec 10, 2020 8:43am EST
Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and Therapy Nov 20, 2020 7:00am EST
Trevena, Inc. to Participate in the Following November Virtual Investor Conferences Nov 09, 2020 7:00am EST
